Prime Medicine, a biotech firm specializing in gene editing therapies, announced an underwritten public offering of 35.7 million common shares priced at $3.50 each, aiming to raise approximately $125 million before expenses. The company also granted underwriters a 30-day option to buy an additional 5.4 million shares. The offering is expected to close around November 12, 2026, and proceeds will support Prime Medicine's development of one-time curative genetic therapies using its proprietary Prime Editing platform. This capital raise is significant for advancing their pipeline focused on liver, lung, immunology, and oncology diseases.
Prime Medicine's public offering news provides context for health sector trading. For readers following health stocks, here is Pluang's market snapshot as of Nov 11, 2026 06:11 WIB: Out of 150 US health stocks, 48 rose and 100 fell. Notable movers include INO at USD 1.34 with a 1-day change of -11.26%, ACAD at USD 18.16 up 10.06%, and IONS at USD 28.22 down 8.97%.
American Healthcare REIT Director Scott A. Estes sold 2,500 shares at $59.32 each following the company’s strong third-quarter earnings report. The company reported a 31.8% increase in normalized funds from operations and a 13.8% rise in same-store n...
Boxes of Hope is partnering with La Frontera to convert dismantled Arizona border wall shipping containers into 350 to 450 affordable rental homes in Tucson. Each 40-foot container will become a comfortable 300 sq ft living space with essential ameni...
Gap Inc. announced a dividend of $0.175 per share for the fourth quarter of fiscal year 2026. The dividend will be paid on or after January 27, 2027, to shareholders recorded by January 6, 2027. This move reflects Gap's ongoing commitment to returnin...
WEBTOON Entertainment's stock has increased by 19.9% even though the company experienced declines in revenue and user numbers. The company's valuation remains high, with a market cap of $1.31 billion compared to an EBITDA forecast of $17.5 million an...
A claim surfaced that Kazakhstan purchased $100 million worth of Bitcoin to create a strategic reserve. However, no official government source, transaction details, or timeline were provided to verify this. The report framed the purchase as part of a...
